580 related articles for article (PubMed ID: 26496816)
21. Expression profile of receptor activator of nuclear-κB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer.
Owen S; Ye L; Sanders AJ; Mason MD; Jiang WG
Anticancer Res; 2013 Jan; 33(1):199-206. PubMed ID: 23267146
[TBL] [Abstract][Full Text] [Related]
22. Pioglitazone affects the OPG/RANKL/RANK system and increase osteoclastogenesis.
Xu F; Dong Y; Huang X; Chen P; Guo F; Chen A; Huang S
Mol Med Rep; 2016 Sep; 14(3):2289-96. PubMed ID: 27430581
[TBL] [Abstract][Full Text] [Related]
23. Effects of 17β-estradiol on adiponectin regulation of the expression of osteoprotegerin and receptor activator of nuclear factor-κB ligand.
Wang QP; Yang L; Li XP; Xie H; Liao EY; Wang M; Luo XH
Bone; 2012 Sep; 51(3):515-23. PubMed ID: 22634178
[TBL] [Abstract][Full Text] [Related]
24. Expression profiles of receptor activator of nuclear factor kappaB ligand, receptor activator of nuclear factor kappaB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones.
Ikeda T; Utsuyama M; Hirokawa K
J Bone Miner Res; 2001 Aug; 16(8):1416-25. PubMed ID: 11499864
[TBL] [Abstract][Full Text] [Related]
25. Receptor activator of nuclear factor-κB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues (review).
Liu W; Zhang X
Mol Med Rep; 2015 May; 11(5):3212-8. PubMed ID: 25572286
[TBL] [Abstract][Full Text] [Related]
26. The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells.
Shin M; Matsuo K; Tada T; Fukushima H; Furuta H; Ozeki S; Kadowaki T; Yamamoto K; Okamoto M; Jimi E
Carcinogenesis; 2011 Nov; 32(11):1634-40. PubMed ID: 21890459
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of microRNA-576-5p protects from steroid-induced avascular necrosis of the femoral head by suppressing ANXA2.
Wang G; Zhang L; Yan C; Zhang Y
Cell Cycle; 2022 Jan; 21(1):49-62. PubMed ID: 34890298
[TBL] [Abstract][Full Text] [Related]
28. Assessment of OPG/RANK/RANKL gene expression levels in peripheral blood mononuclear cells (PBMC) after treatment with strontium ranelate and ibandronate in patients with postmenopausal osteoporosis.
Stuss M; Rieske P; Cegłowska A; Stêpień-Kłos W; Liberski PP; Brzeziańska E; Sewerynek E
J Clin Endocrinol Metab; 2013 May; 98(5):E1007-11. PubMed ID: 23543663
[TBL] [Abstract][Full Text] [Related]
29. Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas.
Mikami S; Katsube K; Oya M; Ishida M; Kosaka T; Mizuno R; Mochizuki S; Ikeda T; Mukai M; Okada Y
J Pathol; 2009 Aug; 218(4):530-9. PubMed ID: 19455604
[TBL] [Abstract][Full Text] [Related]
30. Effect of technetium-99 conjugated with methylene diphosphonate (
Shen S; Wang W; Yang C; Xu B; Zeng L; Qian Y
J Oral Pathol Med; 2019 Feb; 48(2):129-135. PubMed ID: 30421571
[TBL] [Abstract][Full Text] [Related]
31. Regulation of RANKL by biomechanical loading in fibrochondrocytes of meniscus.
Deschner J; Wypasek E; Ferretti M; Rath B; Anghelina M; Agarwal S
J Biomech; 2006; 39(10):1796-803. PubMed ID: 16038916
[TBL] [Abstract][Full Text] [Related]
32. Effect of hydrogen sulphide on the expression of osteoprotegerin and receptor activator of NF-κB ligand in human periodontal ligament cells induced by tension-force stimulation.
Liao C; Hua Y
Arch Oral Biol; 2013 Dec; 58(12):1784-90. PubMed ID: 24200305
[TBL] [Abstract][Full Text] [Related]
33. Expression of the RANK/RANKL/OPG system in the human intervertebral disc: implication for the pathogenesis of intervertebral disc degeneration.
Sano T; Akeda K; Yamada J; Takegami N; Sudo T; Sudo A
BMC Musculoskelet Disord; 2019 May; 20(1):225. PubMed ID: 31101043
[TBL] [Abstract][Full Text] [Related]
34. OPG/RANKL/RANK gene methylation among alcohol-induced femoral head necrosis in northern Chinese men.
Wang T; Wang F; Liu T; Sun M; An F; Liu C; Tian Y; Cao Y; Wang J
J Orthop Surg Res; 2021 Mar; 16(1):223. PubMed ID: 33773583
[TBL] [Abstract][Full Text] [Related]
35. Effect of Wenhua Juanbi Recipe () on expression of receptor activator of nuclear factor kappa B ligand, osteoprotegerin, and tumor necrosis factor receptor superfamily member 14 in rats with collagen-induced arthritis.
Liu XD; Wang YQ; Cai L; Ye LH; Wang F; Feng YY
Chin J Integr Med; 2017 Mar; 23(3):208-214. PubMed ID: 28004300
[TBL] [Abstract][Full Text] [Related]
36. [The function of bushen qiangdu recipe containing serum in OPG/RANKL pathway of ankylosing spondylitis patients].
Xu Y; Ya XP; Zhang WJ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Apr; 32(4):521-4. PubMed ID: 22803436
[TBL] [Abstract][Full Text] [Related]
37. RANK/RANKL/OPG system in the intervertebral disc.
Takegami N; Akeda K; Yamada J; Sano T; Murata K; Huang J; Masuda K; Sudo A
Arthritis Res Ther; 2017 Jun; 19(1):121. PubMed ID: 28576140
[TBL] [Abstract][Full Text] [Related]
38. Osteoprotegerin and RANKL differentially regulate angiogenesis and endothelial cell function.
McGonigle JS; Giachelli CM; Scatena M
Angiogenesis; 2009; 12(1):35-46. PubMed ID: 19105036
[TBL] [Abstract][Full Text] [Related]
39. Expression and Distribution of Receptor Activator of Nuclear Factor Kappa B, Receptor Activator of Nuclear Factor Kappa B Ligand, and Osteoprotegerin in Periradicular Cysts.
Armada L; Marotta Pdos S; Pires FR; Siqueira JF
J Endod; 2015 Aug; 41(8):1281-7. PubMed ID: 25956608
[TBL] [Abstract][Full Text] [Related]
40. Baicalin Ameliorates Dexamethasone-Induced Osteoporosis by Regulation of the RANK/RANKL/OPG Signaling Pathway.
Zhao Y; Wang HL; Li TT; Yang F; Tzeng CM
Drug Des Devel Ther; 2020; 14():195-206. PubMed ID: 32021104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]